封面圖片

The public production of medicines compared to the National Policy of Medicines and the burden of disease in Brazil

Abstract: The public production of medicines in Brazil by Government Pharmaceutical Laboratories has once again become the object of incentives, and Industrial Development Partnerships are one of the mechanisms adopted for the production of strategic medicines for the Brazilian Unified National Heal...

Saved in:

書目詳細資料
Main Authors:	Tatiana Aragão Figueiredo (Author), Joyce Mendes de Andrade Schramm (Author), Vera Lúcia Edais Pepe (Author)
格式:	圖書
出版:	Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2017-09-01T00:00:00Z.
主題:	article
在線閱讀:	Connect to this object online.
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Evidence-based process for decision-making in the analysis of legal demands for medicines in Brazil
由: Tatiana Aragão Figueiredo, et al.
出版: (2013)

Seleção de medicamentos essenciais e a carga de doença no Brasil
由: Tatiana Aragão Figueiredo, et al.
出版: (2014)

O mercado brasileiro de anticorpos monoclonais utilizados para o tratamento de câncer
由: Thaís Jeronimo Vidal, et al.
出版: (2018)

Racionalidade terapêutica: elementos médico-sanitários nas demandas judiciais de medicamentos Racionalidad terapéutica: elementos medico-sanitarios en las demandas judiciales de medicamento Rational therapeutics: health-related elements in lawsuits demanding medicines
由: João Mauricio Brambati Sant'Ana, et al.
出版: (2011)

Caracterização de demandas judiciais de fornecimento de medicamentos "essenciais" no Estado do Rio de Janeiro, Brasil Characterization of lawsuits for the supply of "essential" medicines in the State of Rio de Janeiro, Brazil
由: Vera Lúcia Edais Pepe, et al.
出版: (2010)

"Ao persistirem os sintomas, o médico deverá ser consultado": isto é regulação?
由: Vera Lucia Edais Pepe
出版: (2006)

"Ao persistirem os sintomas, o médico deverá ser consultado": isto é regulação?
由: Vera Lucia Edais Pepe

Diabetes burden in Brazil: fraction attributable to overweight, obesity, and excess weight
由: Luísa Sorio Flor, et al.
出版: (2015)

A definição de medicamentos prioritários para o monitoramento da qualidade laboratorial no Brasil: articulação entre a vigilância sanitária e a Política Nacional de Medicamentos Definition of priority medicines for monitoring laboratory quality in Brazil: the interface between health surveillance and the National Drug Policy
由: Durval Martins Pontes Junior, et al.
出版: (2008)

Sources of medicines for hypertension and diabetes in Brazil: results from the National Health Survey
由: Sotero Serrate Mengue, et al.
出版: (2022)

Public policy coverage and access to medicines in Brazil
由: Ricardo Montes de Moraes, et al.
出版: (2022)

Use of medicines and other products for therapeutic purposes among children in Brazil
由: Tatiane da Silva Dal Pizzol, et al.

Algoritmo para a composição de dados por internação a partir do sistema de informações hospitalares do sistema único de saúde (SIH/SUS) - Composição de dados por internação a partir do SIH/SUS
由: Margareth Crisóstomo Portela, et al.

Algoritmo para a composição de dados por internação a partir do sistema de informações hospitalares do sistema único de saúde (SIH/SUS) - Composição de dados por internação a partir do SIH/SUS
由: Portela Margareth Crisóstomo, et al.
出版: (1997)

Algoritmo para a composição de dados por internação a partir do sistema de informações hospitalares do sistema único de saúde (SIH/SUS) - Composição de dados por internação a partir do SIH/SUS Algorithm for establishing hospital admittance data based on the hospital information system in the Brazilian Unified Health System (SIH/SUS)
由: Margareth Crisóstomo Portela, et al.
出版: (1997)

Racionalidade terapêutica: elementos médico-sanitários nas demandas judiciais de medicamentos
由: João Mauricio Brambati Sant'Ana, et al.

Critérios e indicadores de resultados para a farmácia hospitalar brasileira utilizando o método Delfos Establishment of criteria and outcome indicators for hospital pharmacies in Brazil using Delphos
由: Rachel Magarinos-Torres, et al.
出版: (2007)

Pharmaceutical policies for gaining access to high-priced medicines: a comparative analysis between England and Brazil
由: Geison Vicente, et al.
出版: (2022)

The role of health policy in the burden of breast cancer in Brazil
由: Francisco Winter dos Santos Figueiredo, et al.
出版: (2017)

Morbidity and mortality associated with injuries: results of the Global Burden of Disease study in Brazil, 2008
由: Mônica Rodrigues Campos, et al.
出版: (2015)

Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda
由: Ayo-Oley Baldeh, et al.
出版: (2023)

Complexity of Medicine Regimens and Patient Perception of Medicine Burden
由: Janet Krska, et al.
出版: (2019)

Catastrophic expenditure on medicines in Brazil
由: Vera Lucia Luiza, et al.

Sistema Nacional de Farmacovigilância no Brasil e em Portugal: semelhanças, diferenças e desafios
由: Vera Lúcia Edais Pepe, et al.
出版: (2020)

Novos delineamentos da Assistência Farmacêutica frente à regulamentação da Lei Orgânica da Saúde Nuevos planteamientos de asistencia farmacéutica frente a la regulación de la Ley Orgánica de Salud Essential medicines and technology incorporation following novel Brazilian Public Health System regulations
由: Vera Lúcia Edais Pepe, et al.
出版: (2013)

First use of antineoplastic agents in women with breast cancer in the state of Rio de Janeiro, Brazil
由: Ranailla Lima Bandeira dos Santos, et al.
出版: (2023)

Strengthening access to cancer medicines for children in East Africa: policy options to enhance medicine procurement, forecasting, and regulations
由: Kadia Petricca, et al.
出版: (2024)

Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators
由: Katrina Perehudoff
出版: (2020)

A interação entre prescritores, dispensadores e pacientes: informação compartilhada como possível benefício terapêutico
由: Pepe Vera Lúcia Edais, et al.
出版: (2000)

A interação entre prescritores, dispensadores e pacientes: informação compartilhada como possível benefício terapêutico
由: Vera Lúcia Edais Pepe, et al.

A interação entre prescritores, dispensadores e pacientes: informação compartilhada como possível benefício terapêutico Interaction between prescribers, dispensers, and patients: shared information as a possible therapeutic benefit
由: Vera Lúcia Edais Pepe, et al.
出版: (2000)

National policy for integration of ICT: a comparative study between Brazil and Spain
由: José GOMES DA SILVA, et al.
出版: (2018)

Comparing the Therapeutic Potential of Stem Cells and their Secretory Products in Regenerative Medicine
由: Jhi Biau Foo, et al.
出版: (2021)

Nitrosamines in medicinal products
由: Katarzyna Dominiak, et al.
出版: (2022)

Medicines regulation, pricing and reimbursement in Brazil
由: Adriana M. IVAMA-BRUMMELL, et al.
出版: (2022)

A produção pública de medicamentos no Brasil: uma visão geral Public production of medicines in Brazil: an overview
由: Egléubia Andrade de Oliveira, et al.
出版: (2006)

Animals and their products utilized as medicines by the inhabitants surrounding the Ranthambhore National Park, India
由: Jaroli DP, et al.
出版: (2006)

The Effect of China's National Essential Medicine Policy on Health Expenses: Evidence From a National Study
由: Qian Li PhD, et al.
出版: (2018)

The 21st Century Cures Act: can the regulatory framework survive the "cures"?
由: Claudia Garcia Serpa Osorio-, et al.
出版: (2015)

Comparative price analysis of biological medicines: disparities generated by different pricing policies
由: Marcela Amaral Pontes, et al.
出版: (2024)